NCT05190783

Brief Summary

The purposes of the study to compare partial pulpotomy versus complete pulpotomy in primary molars using three different materials (Formocresol, MTA, Theracal LC) . After 6, 9, 12 and 15 months follow up each case will be evaluated radiographically and clinically. the radiographic criteria to be evaluated are (radiolucency, resorption, widening in periodontal ligament space, Crypt involvement) and clinical criteria are ( pain, tenderness, fistula, abnormal mobility) upon these criteria some recommendations will be made on success and failure rate of each material and each technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2019

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 11, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 13, 2022

Completed
Last Updated

January 18, 2022

Status Verified

February 1, 2019

Enrollment Period

2.4 years

First QC Date

December 11, 2021

Last Update Submit

January 14, 2022

Conditions

Keywords

Partial PulpotomypulpotomyMTATheracalFormocresol

Outcome Measures

Primary Outcomes (1)

  • post operative pain

    numerical/visual analogue scale 0 no pain 10 worst possible pain

    15 months

Secondary Outcomes (7)

  • radiolucency

    15 months

  • fistula

    15 months

  • tooth mobility

    15 months

  • tenderness

    15 months

  • root resorption

    15 months

  • +2 more secondary outcomes

Study Arms (6)

formocresol pulpotomy

EXPERIMENTAL

gold standard arm which pulpotomy will be done with formocresol

Drug: FormocresolProcedure: pulpotomy

formocresol partial pulpotomy

ACTIVE COMPARATOR

partial pulpotomy will be done with formocresol

Drug: FormocresolProcedure: partial pulpotomy

MTA pulpotomy

ACTIVE COMPARATOR

in this group complete pulpotomy will be done with MTA

Drug: MTAProcedure: pulpotomy

MTA partial pulpotomy

ACTIVE COMPARATOR

in this study group partial pulpotomy will be done with MTA

Drug: MTAProcedure: partial pulpotomy

pulpotomy with Theracal LC

ACTIVE COMPARATOR

in this study group complete pulpotomy will be done with Theracal LC

Drug: TheraCalProcedure: pulpotomy

partial pulpotomy with Theracal LC

ACTIVE COMPARATOR

in this study group partial pulpotomy technique will be done with Theracal LC

Drug: TheraCalProcedure: partial pulpotomy

Interventions

mixture of formalin, cresol and glycerine used for fixation of pulp tissues

formocresol partial pulpotomyformocresol pulpotomy
MTADRUG

material used for pulp regeneration, direct and indirect pulp capping

Also known as: Mineral trioxide aggregate
MTA partial pulpotomyMTA pulpotomy

light cured resin modified calcium silicate filled liner designed for use in direct and indirect pulp capping

partial pulpotomy with Theracal LCpulpotomy with Theracal LC
pulpotomyPROCEDURE

removal of the carious tooth structure and unroofing of the pulp chamber with a round carbide bur with high speed and water spray. The coronal pulp tissue will be then removed using a #4 carbide bur with slow speed and sharp spoon excavator.

MTA pulpotomyformocresol pulpotomypulpotomy with Theracal LC

complete removal of caries till exposure occurs. The exposed surface of the pulp will be gently removed using a sterile round diamond bur and a high-speed, water-cooled handpiece with light hand pressure. The removal of the pulp did not exceed approximately two mm.

MTA partial pulpotomyformocresol partial pulpotomypartial pulpotomy with Theracal LC

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • No history of spontaneous or nocturnal pain.
  • History of transient pain of sensitivity resulting from various stimuli: hot, cold and sweets.
  • Patient who had a bilateral deep carious lesion at second primary molars.
  • absence of tenderness to percussion
  • absence of physiologic or pathologic tooth mobility
  • Radiographic evidence of no internal or external resorption.
  • There is not an intraradicular or periapical bone loss or widening of the periodontal ligament space.

You may not qualify if:

  • history of spontaneous or nocturnal pain.
  • Patient who had a unilateral deep carious lesion.
  • presence of tenderness to percussion
  • presence of physiologic or pathologic tooth mobility
  • Radiographic evidence of internal or external resorption.
  • There is an intraradicular or periapical bone loss or widening of the periodontal ligament space.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

Related Publications (11)

  • Smail-Faugeron V, Porot A, Muller-Bolla M, Courson F. Indirect pulp capping versus pulpotomy for treating deep carious lesions approaching the pulp in primary teeth: a systematic review. Eur J Paediatr Dent. 2016 Jun;17(2):107-12.

  • Katz CR, de Andrade Mdo R, Lira SS, Ramos Vieira EL, Heimer MV. The concepts of minimally invasive dentistry and its impact on clinical practice: a survey with a group of Brazilian professionals. Int Dent J. 2013 Apr;63(2):85-90. doi: 10.1111/idj.12018. Epub 2013 Mar 12.

  • Dhar V, Marghalani AA, Crystal YO, Kumar A, Ritwik P, Tulunoglu O, Graham L. Use of Vital Pulp Therapies in Primary Teeth with Deep Caries Lesions. Pediatr Dent. 2017 Sep 15;39(5):146-159.

  • Cvek M, Cleaton-Jones PE, Austin JC, Andreasen JO. Pulp reactions to exposure after experimental crown fractures or grinding in adult monkeys. J Endod. 1982 Sep;8(9):391-7. doi: 10.1016/S0099-2399(82)80092-7. No abstract available.

  • Schroder U, Szpringer-Nodzak M, Janicha J, Wacinska M, Budny J, Mlosek K. A one-year follow-up of partial pulpotomy and calcium hydroxide capping in primary molars. Endod Dent Traumatol. 1987 Dec;3(6):304-6. doi: 10.1111/j.1600-9657.1987.tb00639.x. No abstract available.

  • Parirokh M, Torabinejad M, Dummer PMH. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part I: vital pulp therapy. Int Endod J. 2018 Feb;51(2):177-205. doi: 10.1111/iej.12841. Epub 2017 Sep 21.

  • Camp JH. Diagnosis dilemmas in vital pulp therapy: treatment for the toothache is changing, especially in young, immature teeth. J Endod. 2008 Jul;34(7 Suppl):S6-12. doi: 10.1016/j.joen.2008.03.020.

  • Wunsch PB, Kuhnen MM, Best AM, Brickhouse TH. Retrospective Study of the Survival Rates of Indirect Pulp Therapy Versus Different Pulpotomy Medicaments. Pediatr Dent. 2016 Oct 15;38(5):406-411.

  • George V, Janardhanan SK, Varma B, Kumaran P, Xavier AM. Clinical and radiographic evaluation of indirect pulp treatment with MTA and calcium hydroxide in primary teeth (in-vivo study). J Indian Soc Pedod Prev Dent. 2015 Apr-Jun;33(2):104-10. doi: 10.4103/0970-4388.155118.

  • El Meligy OA, Allazzam S, Alamoudi NM. Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence Int. 2016;47(7):571-80. doi: 10.3290/j.qi.a36095.

  • Poggio C, Arciola CR, Beltrami R, Monaco A, Dagna A, Lombardini M, Visai L. Cytocompatibility and antibacterial properties of capping materials. ScientificWorldJournal. 2014;2014:181945. doi: 10.1155/2014/181945. Epub 2014 May 18.

MeSH Terms

Interventions

formocresolPemetrexedmineral trioxide aggregateTheraCalPulpotomy

Intervention Hierarchy (Ancestors)

GuanineHypoxanthinesPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsGlutamatesAmino Acids, AcidicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, DicarboxylicEndodonticsDentistry

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
the children and their parents are blinded from the material that will be used and the technique
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2021

First Posted

January 13, 2022

Study Start

March 1, 2019

Primary Completion

August 1, 2021

Study Completion

November 1, 2021

Last Updated

January 18, 2022

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will share

planning to publish my paper on pediatric dental journals

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations